Login / Signup

Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).

Joanna C ThornEmma L TurnerEleanor I WalshJenny L DonovanDavid E NealFreddie C HamdyRichard M MartinSian M Noble
Published in: BMC health services research (2023)
Introducing a single PSA screening test for men aged 50-69 across England and Wales could lead to very high initial secondary-care costs.
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • healthcare
  • palliative care
  • quality improvement
  • study protocol
  • open label
  • clinical trial
  • middle aged